OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial - Concepedia

Concepedia

Publication | Open Access

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

DOI Full Paper Access

1K

Citations

37

References

2010

Year

SK Aurora, DW Dodick, CC Turkel, RE DeGryse, SD Silberstein, RB Lipton, HC Diener, MF Brin

Abstract

The results of PREEMPT 2 demonstrate that onabotulinumtoxinA is effective for prophylaxis of headache in adults with chronic migraine. Repeated onabotulinumtoxinA treatments were safe and well tolerated.

References

	Year	Citations

Page 1